These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 21195892)

  • 1. Hepatitis associated with prothionamide for treatment of multidrug-resistant tuberculosis.
    Hsu HL; Bai KJ; Chiang YC; Lin SJ; Yu MC
    J Formos Med Assoc; 2010 Dec; 109(12):923-7. PubMed ID: 21195892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different macrophage polarization between drug-susceptible and multidrug-resistant pulmonary tuberculosis.
    Cho HJ; Lim YJ; Kim J; Koh WJ; Song CH; Kang MW
    BMC Infect Dis; 2020 Jan; 20(1):81. PubMed ID: 31996142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-administered, standardized regimens for multidrug-resistant tuberculosis in South Korea.
    Park SK; Lee WC; Lee DH; Mitnick CD; Han L; Seung KJ
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):361-8. PubMed ID: 15139476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran.
    Baghaei P; Tabarsi P; Dorriz D; Marjani M; Shamaei M; Pooramiri MV; Mansouri D; Farnia P; Masjedi M; Velayati A
    Am J Ther; 2011; 18(2):e29-34. PubMed ID: 20019591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of causes of drug resistance and therapeutic effects on 27 multi-drug resistant pulmonary tuberculosis patients].
    Ye Z; Pei X; Yang Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):234-6. PubMed ID: 10072811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.
    Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR
    J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
    Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
    Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clofazimine in the treatment of multidrug-resistant tuberculosis.
    Xu HB; Jiang RH; Xiao HP
    Clin Microbiol Infect; 2012 Nov; 18(11):1104-10. PubMed ID: 22192631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis.
    Musso M; Mosti S; Gualano G; Mencarini P; Urso R; Ghirga P; Rianda A; Del Nonno F; Goletti D; Palmieri F
    BMC Infect Dis; 2019 Oct; 19(1):882. PubMed ID: 31640579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of prothionamide in patients with multidrug-resistant tuberculosis.
    Lee HW; Kim DW; Park JH; Kim SD; Lim MS; Phapale PB; Kim EH; Park SK; Yoon YR
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1161-6. PubMed ID: 19723408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of Mycobacterium tuberculosis from sputum of tribal, non-tribal pulmonary tuberculosis patients of Andaman & Nicobar islands by conventional culture method and assessment of first line anti-tuberculosis drug susceptibility patterns.
    Mandal A; Parthasarathy G; Burma SP; Sugunan AP; Vijayachari P
    Indian J Tuberc; 2015 Jan; 62(1):23-8. PubMed ID: 25857562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A survey on resistance to second-line drugs in patients with pulmonary tuberculosis in Shanghai, China].
    Shen X; Li J; Gao Q; Xu B; Mei J
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):451-3. PubMed ID: 21781519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the use of ethionamide and prothionamide in childhood tuberculosis.
    Thee S; Garcia-Prats AJ; Donald PR; Hesseling AC; Schaaf HS
    Tuberculosis (Edinb); 2016 Mar; 97():126-36. PubMed ID: 26586647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from a randomised clinical trial for multidrug-resistant tuberculosis.
    Padayatchi N; Mac Kenzie WR; Hirsch-Moverman Y; Feng PJ; Villarino E; Saukkonen J; Heilig CM; Weiner M; El-Sadr WM
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1582-7. PubMed ID: 23131255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand.
    Reechaipichitkul W
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of extensively drug-resistant tuberculosis on treatment outcome of multidrug-resistant tuberculosis patients with standardized regimen: report from Iran.
    Tabarsi P; Chitsaz E; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Amiri M; Mansouri D; Masjedi MR; Velayati AA; Caminero JA
    Microb Drug Resist; 2010 Mar; 16(1):81-6. PubMed ID: 20192820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of resistance in multi drug resistant tuberculosis patients.
    Irfan S; Hassan Q; Hasan R
    J Pak Med Assoc; 2006 Sep; 56(9):397-400. PubMed ID: 17091751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.